A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, Deng X, Huang S, Lin C, Lu T. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110(3):398–403.

Article  PubMed  Google Scholar 

Wu MY, He XY, Hu CS. Tumor regression and patterns of distant metastasis of T1–T2 nasopharyngeal carcinoma with intensity-modulated radiotherapy. PLoS ONE. 2016;11(4): e0154501.

Article  PubMed  PubMed Central  Google Scholar 

Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684–90.

Article  PubMed  PubMed Central  Google Scholar 

Pinker K, Andrzejewski P, Baltzer P, Polanec SH, Sturdza A, Georg D, Helbich TH, Karanikas G, Grimm C, Polterauer S, et al. Multiparametric [18F]Fluorodeoxyglucose/[18F]Fluoromisonidazole positron emission tomography/magnetic resonance imaging of locally advanced cervical cancer for the non-invasive detection of tumor heterogeneity: a pilot study. PLoS ONE. 2016;11(5):e0155333.

Article  PubMed  PubMed Central  Google Scholar 

Yoon SH, Park CM, Park SJ, Yoon JH, Hahn S, Goo JM. Tumor heterogeneity in lung cancer: assessment with dynamic contrast-enhanced MR imaging. Radiology. 2016;280(3):940–8.

Article  PubMed  Google Scholar 

Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–77.

Article  PubMed  Google Scholar 

Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–62.

Article  PubMed  Google Scholar 

Chen FP, Lin L, Qi ZY, Zhou GQ, Guo R, Hu J, Lin AH, Ma J, Sun Y. Pretreatment nomograms for local and regional recurrence after radical radiation therapy for primary nasopharyngeal carcinoma. J Cancer. 2017;8(13):2595–603.

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Huang Y, Hong S, Yang Y, Yu G, Jia J, Peng P, Wu X, Lin Q, Xi X, et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. Lancet. 2016;388(10054):1883–92.

Article  CAS  PubMed  Google Scholar 

Mao YP, Xie FY, Liu LZ, Sun Y, Li L, Tang LL, Liao XB, Xu HY, Chen L, Lai SZ, et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009;73(5):1326–34.

Article  PubMed  Google Scholar 

Ouyang FS, Guo BL, Zhang B, Dong YH, Zhang L, Mo XK, Huang WH, Zhang SX, Hu QG. Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III–IVb nasopharyngeal carcinoma. Oncotarget. 2017;8(43):74869–79.

Article  PubMed  PubMed Central  Google Scholar 

Zhang B, Ouyang F, Gu D, Dong Y, Zhang L, Mo X, Huang W, Zhang S. Advanced nasopharyngeal carcinoma: pre-treatment prediction of progression based on multi-parametric MRI radiomics. Oncotarget. 2017;8(42):72457–65.

Article  PubMed  PubMed Central  Google Scholar 

Zhang LL, Huang MY, Li Y, Liang JH, Gao TS, Deng B, Yao JJ, Lin L, Chen FP, Huang XD, et al. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. EBioMedicine. 2019;42:270–80.

Article  PubMed  PubMed Central  Google Scholar 

Pfister D. NCCN Clinical PracticeGuidelines in Oncology (NCCN Guidelines) Head andNeck Cancers Version 3.2021-April 27. 2021.

Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B (Methodol). 1996;58(1):267–88.

Google Scholar 

Nicolas DJ, Simon PC, Catharina O, Nehme EH, Gianluca B, Benjamin HK. mRMRe: an R package for parallelized mRMR ensemble feature selection. Bioinformatics. 2013;29(18):2365–8.

Article  Google Scholar 

Hepp T, Schmid M, Gefeller O, Waldmann E, Mayr A. Approaches to regularized regression—a comparison between gradient boosting and the lasso. Methods Inf Med. 2016;55(5):422–30.

Article  PubMed  Google Scholar 

Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z, Liang C, Tian J, Liang C. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology. 2016;281(3):947–57.

Article  PubMed  Google Scholar 

Ming X, Oei RW, Zhai R, Kong F, Du C, Hu C, Hu W, Zhang Z, Ying H, Wang J. MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma. Sci Rep. 2019;9(1):10412.

Article  PubMed  PubMed Central  Google Scholar 

Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–64.

Article  PubMed  Google Scholar 

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173-180.

Article  PubMed  PubMed Central  Google Scholar 

Ng SH, Chang TC, Ko SF, Yen PS, Wan YL, Tang LM, Tsai MH. Nasopharyngeal carcinoma: MRI and CT assessment. Neuroradiology. 1997;39(10):741–6.

Article  CAS  PubMed  Google Scholar 

Kickingereder P, Burth S, Wick A, Götz M, Eidel O, Schlemmer HP, Maier-Hein KH, Wick W, Bendszus M, Radbruch A, et al. Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models. Radiology. 2016;280(3):880–9.

Article  PubMed  Google Scholar 

Liu J, Mao Y, Li Z, Zhang D, Zhang Z, Hao S, Li B. Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma. J Magn Reson Imaging. 2016;44(2):445–55.

Article  PubMed  Google Scholar 

Akram F, Koh PE, Wang F, Zhou S, Tan SH, Paknezhad M, Park S, Hennedige T, Thng CH, Lee HK, et al. Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy. PLoS ONE. 2020;15(10):e0240043.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Fogg M, Wirth LJ, Daley H, Ritz J, Posner MR, Wang FC, Lorch JH. Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma. Cancer. 2017;123(14):2642–50.

Article  CAS  PubMed  Google Scholar 

Zhou GQ, Tang LL, Mao YP, Chen L, Li WF, Sun Y, Liu LZ, Li L, Lin AH, Ma J. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis. Int J Radiat Oncol Biol Phys. 2012;82(3):e359-365.

Article  CAS  PubMed  Google Scholar 

Xia WX, Zhang HB, Shi JL, Lu X, Wang L, Ye YF, Cao KJ, Qian CN, Guo X, Xiang YQ. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. Eur J Cancer. 2013;49(9):2152–60.

Article  CAS  PubMed  Google Scholar 

Differding S, Hanin FX, Grégoire V. PET imaging biomarkers in head and neck cancer. Eur J Nucl Med Mol Imaging. 2015;42(4):613–22.

Article  CAS  PubMed  Google Scholar 

Choi ER, Lee HY, Jeong JY, Choi YL, Kim J, Bae J, Lee KS, Shim YM. Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma. Oncotarget. 2016;7(41):67302–13.

Article  PubMed  PubMed Central  Google Scholar 

Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.

Article  CAS  PubMed  Google Scholar 

Yan G, Feng Y, Wu M, Li C, Wei Y, Hua L, Zhao G, Hu Z, Yao S, Hou L, et al. Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma. Radiat Oncol. 2022;17(1):111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo HS, Chen YY, Huang WZ, Wu SX, Huang SF, Xu HY, Xue RL, Du ZS, Li XY, Lin LX, et al. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiat Oncol. 2021;16(1):201.

Article  PubMed  PubMed Central  Google Scholar 

Drukker K, Li H, Antropova N, Edwards A, Papaioannou J, Giger ML. Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer. Cancer Imaging. 2018;18(1):12.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif